| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |